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A B S T R A C T
Precursor T-cell acute lymphoblastic leukaemia (T-ALL)/lymphoma (T-LBL) is a neoplasm with cytological features
that include blast cells of medium size, high nuclear cytoplasmic ratio and inconspicuous nucleoli, which are usually
TdT (Terminal Deoxynucleotidyl Transferase) positive and variably express T-cell markers. We report a case of T-ALL
with atypical cytological presentation which showed lymphoblasts with homogenous nuclear pattern, larger amounts of
cytoplasm with vacuoles and prominent nucleoli. A 56-year-old male was hospitalized due to high fever and kidney infec-
tion. Further examination confirmed anemia, thrombocytopenia, normal level of white blood cells and high level of
lactat-dehidrogenase (LDH). Bone marrow aspiration revealed 87% and peripheral blood 41% of lymphoblasts with cyto-
plasmic vacuoles which suggested Burkitt lymphoma (BL) morphology. Patient’s karyotype showed no chromosomal
aberations. Identification of immunophenotype discovered cells which were CD2 and CD3 positive and CD20 negative
with focal acid phosphatase activity in 67% of blasts. This excluded Burkitt lymphoma and led to diagnosis of T-ALL.
The patient was submitted to two cycles of chemotherapy, autologous stem cell transplantation, and intrathecal chemo-
therapy, but he died after 10 months because of disease complications (lung aspergillosis and pleural effusion). Our case
report showed how morphology alone can be misleading and sometimes is not enough in diagnosing ALL. Beside
morphologic criteria, setting correct diagnosis depends on identification of immunophenotype by flow cytometry and
cytogenetic-molecular abnormalities. Further improvements in the molecular definition of ALL subtypes, development of
new and targeted drugs will improve patient’s outcome and prognosis.
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Introduction
The differential diagnosis between T-ALL and other
B-cell malignancies is possible only by immunopheno-
type. T-ALL shows a quite variable cytological pattern
ranging from monomorphous, medium size cells with
high nuclear cytoplasmic ratio to large cells with promi-
nent nucleoli. Cytoplasmic vacuoles and »starry-sky« ef-
fect are occasionally seen. The number of mitotic figures
is reported to be higher in T-All than B-ALL1.
T-ALL is clinically usually presented with high leuko-
cyte number and T-LBL with large mediastinal mass and
pleural effusions1,2. T-ALL has poor prognosis especially
in older adults with higher blood cell counts3. Complica-
tions, such as bacterial sepsis and opportunistic infec-
tions with Cytomegalovirus (CMV), Candida, Pneumo-
cystis carinii can occur at any time during course of
treatment4. Meningeal involvement is also common. We
present a case of T-ALL with leukaemic manifestation of
disease and cytological features which might suggest
Burkitt lymphoma. The final diagnosis of T-ALL was
made by identification of cell immunophenotype.
Case Report
A 56-year-old male was first hospitalized at the begin-
ning of July 2008 because of high fever and kidney infec-
tion. Laboratory results showed normal white blood count
– WBC (4.07109/L), anemia (red blood count – RBC
675
Received for publication November 21, 2009
3.401012/L, hemoglobin 96 g/L), thrombocytopenia (pla-
telet count 8109/L) and high level of LDH (1512 U/L).
The patient was submitted to bone marrow aspiration.
The smears revealed hypercellular bone marrow with
87% and peripheral blood with 41% of lymphoblasts
whose morphology showed round shaped nuclei, homoge-
neous nuclear pattern, mitoses and cytoplasmic vacuoles
which suggested Burkitt lymphomamorphology (Figure 1).
Immunocytochemistry yielded positive reaction to CD2
in 93% of blasts (Figure 2) and CD3 (Figure 3), however
negative reaction to CD 20 and TdT. These results ex-
cluded the B-cell origin of the disease. Blasts showed neg-
ative cytochemical reaction to myeloperoxidase (MPO),
nonspecific esterase (ANAE), and Periodic Acid Schiff
(PAS), while acid phosphatase revealed positivity in 67%
of blasts (Figure 4). On flow cytometry, the phenotype of
blasts was cytCD3+, CD2+, CD5+, CD7+, CD1a+,
CD4+/–, CD8+/–, CD10–, CD3–, TdT–. Based on the
morphology, cytochemical characteristics and immuno-
phenotype, it was considered a case of T-ALL. On the ba-
sis of banded chromosomes and fluorescent in situ hy-
bridization (FISH), cytogenetic analysis showed no
abnormalities. Bone marrow biopsy was also performed
and confirmed the diagnosis of T-ALL. He received in-
duction chemotherapy Hyper – CVAD protocol (cyclo-
phosphamide, vincrystine, adriamycin, dexamethasone).
In October 2008 the patient was admitted for another
chemotherapy treatment, but the recovery was compli-
cated by high fever and pancytopenia. In November 2008
the patient was submitted to autologous stem cell trans-
plantation. Despite these efforts, he went into relapse
and two months later the bone marrow smear revealed
the presence of 27% of lymphoblasts. Evidence of menin-
geal involvement was documented by lumbar puncture
and his condition gotten worse in spite of intrathecal che-
motherapy. Laboratory results in March 2009 showed
anaemia, thrombocytopenia and leukocytopenia. In May
2009 cytology confirmed another relapse of disease and
revealed 62% of blasts in peripheral blood and 63% of
blasts in bone marrow. The patient deceased due to disea-
se complications, lung aspergillosis and pleural effusion.
Discussion and Conclusion
T-ALL/LBL is a neoplasm committed to the T-cell lin-
eage. It comprises about 20–25% of adult cases of ALL
and about 85–90% of LBL. The aetiology is unknown1.
Although some studies indicate that many patients can
be cured with chemotherapy alone2, T-ALL/LBL is still a
disease with unfavorable prognosis with median survival
of about 12 months4. The use of terms leukaemia/lym-
phoma is arbitrary depending on blood and bone marrow
involvement. If patient presents with a mass lesion and
25% or fewer lymphoblasts in the marrow, the term lym-
phoma is preferred1. The aetiology of these tumors is un-
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Fig. 1. Lymphoblasts in bone marrow showing round shaped
nuclei, homogenous nuclear pattern, mitoses and cytoplasmic
vacuoles (May-Grünwald-Giemsa, 1000).
Fig. 2. Bone marrow lymphoblasts showing CD2 positivity on
immunocytochemical stains (LSAB, 1000).
Fig. 3. Bone marrow smear showing lymphoblasts which are
CD3 positive on immunocytochemical stains (LSAB, 1000).
Fig. 4. Lymphoblasts in bone marrow showing focal acid
phosphatase activity (cytochemistry, 1000).
known, but it is shown to be associated with HTLV1 (hu-
man T-cell leukaemia virus type 1) infection in parts of
the world where the virus is endemic like Japan, South
America, parts of Africa4–7. Infection usually remains la-
tent for decades, and only 3–10% of infected individuals
develop leukaemia4. The treatments of T-ALL and Bur-
kitt lymphoma are generally different and BL shows
better prognosis than T-ALL1.
The present case was unusual because cytologically
he was presented with lymphoblasts whose morphology
might suggest Burkitt lymphoma/leukaemia. Lympho-
blasts in T-ALL/LBL (L1, L2) are usually cells of medium
size with high nuclear cytoplasmic ratio2,5. The cell size
and morphology vary from small blasts with scant cyto-
plasm, condensed nuclear chromatin and no evident nu-
cleoli to larger blasts with moderate amounts of light-
-blue, grey cytoplasm, finely dispersed chromatin and
prominent nucleoli1,8. The nucleus shape can be round,
irregular or indented. Lymphoblasts in Burkitt lympho-
ma are medium-size cells whose nuclei are round with
homogeneous nuclear pattern and centrally placed nu-
cleoli. The cytoplasm is deeply basophilic and contains
numerous lipid vacuoles1,2. Immunophenotypic features
of T-ALL/LBL include TdT positivity and expression of
CD1a, CD2, CD3, CD4, CD5, CD7 and CD8 antigens1.
CD10 may also be positive and those patients are more
likely to achieve remission3.
When our patient was submitted to the first bone
marrow aspiration, smear revealed blast morphology ty-
pical for Burkitt lymphoma. Therefore we expected mar-
kers positive for B-cell lineage. In spite of our expecta-
tion, CD20 turned out to be negative and so were cyto-
chemical reactions such as PAS, MPO and ANAE which
excluded myeloid and B-cell origin of disease. Blasts re-
vealed CD2 and CD3 positivity (Figure 3) on immuno-
cytochemical staining along with acid phosphatase activ-
ity. Differential diagnosis of T-ALL includes B-ALL, acute
myeloid leukaemia1 which was excluded by immuno-
phenotype and cytochemical analysis. This confirmed
our suspicion that patient’s diagnosis was T-ALL in spite
of cell morphology which suggested Burkitt lymphoma.
Our case report showed how morphology alone can be
misleading. It points out that today the French-Ameri-
can-British (FAB) distinction of L1, L2 and L3 mor-
phologies is no longer relevant. Identification of the
immunophenotype has become a major part of diagnos-
ing ALL5.
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T LIMFOBLASTI^NA LEUKEMIJA SA NEUOBI^AJENOM MORFOLOGIJOM BURKITOVOG
LIMFOMA – PRIKAZ SLU^AJA
S A @ E T A K
Prekursorska T-akutna limfoblasti~na leukemija/limfom (T-ALL/LBL) je bolest morfolo{ki karakterizirana srednje
velikim limfoblastima s visokim omjerom jezgre i citoplazme i diskretnim nukleolima. Limfoblasti su prete`no TdT
(Terminalna Deoksinukleotidil Transferaza) pozitivni uz razli~ito izra`avanje T-stani~nih biljega (CD1a, CD2, CD3,
CD4, CD5, CD7 i CD8). Prikazujemo slu~aj T-ALL-a atipi~ne citolo{ke slike s limfoblastima, homogene strukture kro-
matina, izra`enih nukleola te izrazito vakuolizirane citoplazme. 56-godi{nji mu{karac je hospitaliziran zbog vru}ice i
infekcije urotrakta. Dodatne pretrage pokazale su anemiju i trombocitopeniju te visoku razinu laktat-dehidrogenaze
(LDH) uz uredan broj leukocita. U punktatu ko{tane sr`i na|eno je 87% a u perifernoj krvi 41% limfoblasta izrazito
vakuolizirane citoplazme, {to je sugeriralo morfologiju Burkittovog limfoma (BL). Kariotip nije pokazao kromosomske
aberacije. Imunofenotipski blasti su bili CD2 i CD3 pozitivni a CD20 negativni, s fokalnom citokemijskom pozitivno{}u
kisele fosfataze u 67% stanica. Na osnovu toga je isklju~en Burkittov limfom te je postavljena dijagnoza T-ALL-a. Na-
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kon dva ciklusa kemoterapije pacijent je podvrgnut autolognoj transplantaciji ko{tane sr`i i intratekalnoj kemoterapiji.
Unato~ provedenoj terapiji, bolesnik umire nakon 10 mjeseci zbog komplikacija bolesti (plu}na aspergiloza i pleuralni
izljev). Na{ slu~aj pokazuje kako ponekad sama morfolo{ka slika nije dovoljna za postavljenje dijagnoze ALL-a. Osim
morfolo{kih kriterija, za ispravnu dijagnozu neophodno je odrediti imunofenotip limfoblasta te prisutnost citogenet-
sko-molekularnih abnormalnosti. Budu}i napretci u molekularnim definiranjima ALL subtipova i razvoj novih ciljanih
lijekova pobolj{at }e ishod i prognozu pacijenata.
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